http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107523646-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_08a51b640e8e51b416aa1985086681f0 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-686 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2017-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84efe7ef1b3cb8262f60a9d6db1aac84 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f494ce1a912a5f178dee215f6ffe121c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad4aa39bd13be533b4ee8cbd1697de6f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1072c1d20e25ac53f2b6f22cb5ec075b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_761ea981c36c2359e8bffc38e4b31b76 |
| publicationDate | 2017-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107523646-A |
| titleOfInvention | Method based on nucleic acid mass-spectrometric technique detection early diagnosing mammary cancer related gene |
| abstract | The invention belongs to field of gene detection, and in particular to a kind of method based on nucleic acid mass-spectrometric technique detection early diagnosing mammary cancer related gene.The present invention provides the combined detection method of 15 mutational sites related to breast cancer of 4 genes and 18 breast cancer susceptibility SNP sites of 10 genes, and Genotyping detection is carried out to the SNP site of breast cancer susceptibility gene and the gene mutation site related to breast cancer using SequenomMassARRAYSNP genotypings technology.This method for breast cancer early screening is more accurate, technique reproducible is good, cost-effective；The SNP detections being sequenced compared to TaqMan PCR and two generation platforms, with flexible design, accuracy is high, detection site sample size is big, low cost and other advantages, can carry out hundreds of to thousands of parts of pattern detections to dozens of SNP site simultaneously. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109457031-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108034723-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111662979-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108060229-A |
| priorityDate | 2017-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 81.